C12N 2750/14145
Special targeting system for viral vectors
C12N2750/14145 (Special targeting system for viral vectors) appears on 260 US grants and 726 published applications in this corpus.
Search patents in C12N- Granted patents
- 260
- Published applications
- 726
- Assignees
- 247
- Inventors
- 1,141
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 3 |
| 2003 | 1 | 4 |
| 2004 | 0 | 4 |
| 2005 | 1 | 2 |
| 2006 | 2 | 7 |
| 2007 | 3 | 3 |
| 2008 | 1 | 2 |
| 2009 | 2 | 10 |
| 2010 | 2 | 9 |
| 2011 | 1 | 3 |
| 2012 | 2 | 8 |
| 2013 | 3 | 12 |
| 2014 | 9 | 13 |
| 2015 | 5 | 12 |
| 2016 | 7 | 16 |
| 2017 | 14 | 23 |
| 2018 | 12 | 30 |
| 2019 | 17 | 32 |
| 2020 | 16 | 38 |
| 2021 | 24 | 39 |
| 2022 | 21 | 51 |
| 2023 | 26 | 89 |
| 2024 | 32 | 90 |
| 2025 | 33 | 142 |
| 2026 | 25 | 84 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof15 Sep 2026US 12,735,459 B2Genzyme Corporation
- Engineered muscle targeting compositions30 Jun 2026US 12,668,814 B2Massachusetts Institute of Technology
- Targeting peptides for directing adeno-associated viruses (AAVs)16 Jun 2026US 12,653,904 B2California Institute of Technology
- Modified AAV capsids and uses thereof16 Jun 2026US 12,653,909 B2Solid Biosciences Inc.
- Capsid variants and methods of using the same16 Jun 2026US 12,655,180 B2Dyno Therapeutics, Inc.
- Adeno-associated virus vector delivery of b-sarcoglycan and microrna-29 and the treatment of muscular dystrophy8 Oct 2026US 2026/0308212 A1Research Institute At Nationwide Children's Hospital
- Targeting aav capsids, methods of manufacturing and using same8 Oct 2026US 2026/0308615 A1REGENXBIO Inc.
- Modified aav vectors for gene therapy1 Oct 2026US 2026/0295079 A1The Trustees of Indiana University
- Methods of treating oxidized phosphatidylcholine-associated diseases1 Oct 2026US 2026/0297217 A1
- Aav capsid variants and uses thereof24 Sep 2026US 2026/0284224 A1Voyager Therapeutics, Inc.
Most cited
By later US patents
- Virus vectors and methods of making and administering the same197US 7,172,893 B2The University of North Carolina at Chapel Hill · 2007
- Recombinant parvovirus vectors and method of making167US 6,491,907 B1The University of North Carolina at Chapel Hill · 2002
- AAV's and uses thereof123US 8,734,809 B2University of Massachusetts · 2014
- AAV2 vectors and methods109US 6,962,815 B2Children's Hopital Inc. · 2005
- Isolation of novel AAV'S and uses thereof107US 9,217,155 B2University of Massachusetts · 2015